Clinical Trial

Biweekly Long-term Occidiofungin Study for Suppression of Mycotic Recurrence

Name: Biweekly Long-term Occidiofungin Study for Suppression of Mycotic Recurrence — clinical trial record (NCT07521137)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: BLOSSOM

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

A Randomized, Double-Blind, Placebo-Controlled Phase 2a Study Evaluating the Safety, Tolerability, and Efficacy of OCF001 Intravaginal Gel in Women with Acute Vulvovaginal Candidiasis

Protocol Amendment History 1 change

critical Recruitment opened 2026-06-16

Trial Details

NCT Number	NCT07521137
Lead Sponsor	Sano Chemicals Inc
Conditions	Candidiasis, Vulvovaginal
Enrollment	36 participants
Start Date	2026-06-04
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-15